ReviewFrontiers in pharmacology2021

Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease.

Yumin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.